MedElevator Войти в исследования
← Поиск публикаций
Медицинская библиотека · The Journal of invasive cardiology · 2011

Transcatheter aortic valve implantation (TAVI) outcome according to standardized endpoint definitions by the Valve Academic Research Consortium (VARC).

Stähli Barbara E, Bünzli Reto, Grünenfelder Jürg, Bühler Ines, Felix Christian, Bettex Dominique, Biaggi Patric, Tanner Felix C, Nguyen-Kim Dan Linh, Plass André, Ge Heng, Falk Volkmar, Lüscher Thomas F, Corti Roberto, Maier Willibald, Altwegg Lukas A

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Transcatheter aortic valve implantation (TAVI) has become an accepted treatment option for severe aortic stenosis (AS) in high-risk individuals. Yet, current results are difficult to compare given the lack of standardized definitions.

METHODS AND

RESULTS

TAVI was performed in 130 high-risk individuals. The Edwards SAPIEN (n = 50) and the Medtronic CoreValve (n = 80) prostheses were implanted by transfemoral (75%) or transapical (25%) access. Outcomes at 30 days and 1 year are reported according to the newly established Valve Academic Research Consortium (VARC) criteria. Median follow-up was 235 days (range, 44-490 days). Thirty-day device success was high (91.5%). Combined safety endpoint at 30 days was 20.8%, with an all-cause mortality of 11.5%. Major vascular complications (11.5%), life-threatening or disabling bleeding (8.5%), and acute kidney injury (6.2%) were further major adverse events. At 1-year follow-up, valve performance was accurate in 94.7% of patients. However, prosthetic-valve associated complications, such as new left bundle branch block (20.0%) or permanent pacemaker implantation (34.7%), were common; cumulative prosthetic-valve associated complications were significantly more frequent in patients treated with a Medtronic CoreValve prosthesis (p = 0.0012). Overall 1-year survival was 80%, with the VARC combined efficacy endpoint (composite of survival, freedom from therapy failure, and accurate valve performance) met in 70.2%. In particular, at 1 year, 68.5% of the patients were living independently at home.

CONCLUSION

The newly established VARC standardized definitions are useful for TAVI outcome reporting.

Для цитирования: Stähli Barbara E, Bünzli Reto, Grünenfelder Jürg, Bühler Ines, Felix Christian, Bettex Dominique, Biaggi Patric, Tanner Felix C, Nguyen-Kim Dan Linh, Plass André, Ge Heng, Falk Volkmar, Lüscher Thomas F, Corti Roberto, Maier Willibald, Altwegg Lukas A. Transcatheter aortic valve implantation (TAVI) outcome according to standardized endpoint definitions by the Valve Academic Research Consortium (VARC).. The Journal of invasive cardiology. 2011.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.